Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention
Circulation. Cardiovascular quality and outcomes - United States
doi 10.1161/circoutcomes.115.002043
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)